[AMRX] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -72.31%
YoY- -56.25%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 659,191 557,540 497,633 493,105 498,533 446,120 275,189 15.65%
PBT -75,522 -9,426 -9,921 14,904 13,344 -133,180 52,016 -
Tax 6,156 668 -3,461 359 -108,173 -8,428 364 60.14%
NP -91,643 -10,094 -6,460 6,706 115,067 -47,881 51,535 -
Tax Rate - - - -2.41% 810.65% - -0.70% -
Total Cost 750,834 567,634 504,093 486,399 383,466 494,001 223,654 22.34%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -13.90 -1.81 -1.30 1.36 23.08 -10.73 18.73 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.30 -0.07 -0.04 0.05 0.78 -0.37 0.45 -
EPS Diluted -0.30 -0.07 -0.04 0.04 0.78 -0.37 0.45 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.